Align Technology, Inc. (ALGN) EV/EBIT Ratio: 19.06x
Is Align Technology, Inc.’s EV/EBIT ratio high or low?
Align Technology, Inc.'s EV/EBIT ratio of 19.06x is 39% below its 5-year average of 31.46x, near the low end of its 5-year range (13.80x–101.20x).
As of Thursday, June 11, 2026. 1.21% below its 12-month average of 19.29x.
ALGN EV/EBIT Ratio Chart
ALGN Average EV/EBIT Ratio Chart
ALGN Current vs Average EV/EBIT Ratio Chart
ALGN EV/EBIT Ratio Metrics
EV/EBIT RATIO
19.06x
EV/EBIT RATIO AVG TTM
19.29x
EV/EBIT RATIO AVG 3Y
26.45x
EV/EBIT RATIO AVG 5Y
31.46x
EV/EBIT RATIO AVG 10Y
43.82x
EV/EBIT RATIO AVG 15Y
42.86x
EV/EBIT RATIO AVG 20Y
42.03x
CURRENT VS TTM AVG
-1.21%
CURRENT VS 3Y AVG
-27.94%
CURRENT VS 5Y AVG
-39.42%
CURRENT VS 10Y AVG
-56.50%
CURRENT VS 15Y AVG
-55.53%
CURRENT VS 20Y AVG
-54.66%
ALGN Competitors' EV/EBIT Ratio
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Align Technology, Inc. (ALGN) | $12.27B | 19.06x | 19.29x | 26.45x | 31.46x |
| Baxter International Inc. (BAX) | $10.49B | N/A | 442.63x | 243.35x | 134.31x |
| Charles River Laboratories International, Inc. (CRL) | $8.94B | 25.21x | 62.77x | 38.53x | 35.14x |
| Bio-Rad Laboratories, Inc. (BIO) | $7.92B | 36.82x | 38.06x | 32.83x | 33.28x |
| Hologic, Inc. (HOLX) | $16.97B | 24.28x | 22.66x | 24.05x | 18.32x |
| Hims & Hers Health, Inc. (HIMS) | $6.19B | 232.28x | 99.26x | 147.55x | 147.55x |
| Moderna, Inc. (MRNA) | $18.71B | N/A | 23.08x | 30.94x | 30.94x |
| BioNTech SE (BNTX) | $22.39B | N/A | 4.91x | 5.85x | 5.85x |
| Mettler-Toledo International Inc. (MTD) | $22.82B | 21.89x | 26.08x | 26.29x | 29.24x |
| Waters Corporation (WAT) | $23.21B | 54.26x | 27.55x | 26.51x | 26.24x |
Align Technology, Inc. EV/EBIT Ratio Formula & Definition
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Align Technology, Inc. EV/EBIT Ratio FAQ
- What is the EV/EBIT ratio for Align Technology, Inc. (ALGN)?
- The EV/EBIT ratio for ALGN stock is 19.06x.
- Is Align Technology, Inc.'s EV/EBIT ratio high or low?
- Align Technology, Inc.'s EV/EBIT ratio of 19.06x is 39% below its 5-year average of 31.46x, near the low end of its 5-year range (13.80x–101.20x).
- What is the TTM average EV/EBIT ratio for Align Technology, Inc. (ALGN)?
- The TTM average EV/EBIT ratio for ALGN stock is 19.29x.
- What is the 3Y average EV/EBIT ratio for Align Technology, Inc. (ALGN)?
- The 3Y average EV/EBIT ratio for ALGN stock is 26.45x.
- What is the 5Y average EV/EBIT ratio for Align Technology, Inc. (ALGN)?
- The 5Y average EV/EBIT ratio for ALGN stock is 31.46x.
- What is the 10Y average EV/EBIT ratio for Align Technology, Inc. (ALGN)?
- The 10Y average EV/EBIT ratio for ALGN stock is 43.82x.
- What is the 15Y average EV/EBIT ratio for Align Technology, Inc. (ALGN)?
- The 15Y average EV/EBIT ratio for ALGN stock is 42.86x.
- What is the 20Y average EV/EBIT ratio for Align Technology, Inc. (ALGN)?
- The 20Y average EV/EBIT ratio for ALGN stock is 42.03x.
Align Technology, Inc. EV/EBIT Ratio History
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-06-11 | 19.06x |
| 2026-06-10 | 18.99x |
| 2026-06-09 | 19.91x |
| 2026-06-08 | 19.18x |
| 2026-06-05 | 18.65x |
| 2026-06-04 | 18.72x |
| 2026-06-03 | 17.93x |
| 2026-06-02 | 18.53x |
| 2026-06-01 | 18.90x |
| 2026-05-29 | 19.53x |
| 2026-05-28 | 19.32x |
| 2026-05-27 | 18.07x |
| 2026-05-26 | 18.15x |
| 2026-05-22 | 18.16x |
| 2026-05-21 | 18.09x |
| 2026-05-20 | 18.13x |
| 2026-05-19 | 17.13x |
| 2026-05-18 | 17.57x |
| 2026-05-15 | 17.39x |
| 2026-05-14 | 17.78x |
| 2026-05-13 | 17.93x |
| 2026-05-12 | 18.42x |
| 2026-05-11 | 18.28x |
| 2026-05-08 | 18.78x |
| 2026-05-07 | 18.73x |
| 2026-05-06 | 19.41x |
| 2026-05-05 | 20.26x |
| 2026-05-04 | 20.67x |
| 2026-05-01 | 21.59x |
| 2026-04-30 | 21.21x |
| 2026-04-29 | 21.52x |
| 2026-04-28 | 21.37x |
| 2026-04-27 | 22.34x |
| 2026-04-24 | 22.98x |
| 2026-04-23 | 23.12x |
| 2026-04-22 | 23.82x |
| 2026-04-21 | 23.71x |
| 2026-04-20 | 23.25x |
| 2026-04-17 | 23.04x |
| 2026-04-16 | 22.38x |
| 2026-04-15 | 22.58x |
| 2026-04-14 | 22.34x |
| 2026-04-13 | 21.82x |
| 2026-04-10 | 20.83x |
| 2026-04-09 | 21.02x |
| 2026-04-08 | 21.32x |
| 2026-04-07 | 20.02x |
| 2026-04-06 | 20.67x |
| 2026-04-02 | 20.50x |
| 2026-04-01 | 20.78x |
| 2026-03-31 | 20.61x |
| 2026-03-30 | 19.94x |
| 2026-03-27 | 19.95x |
| 2026-03-26 | 21.38x |
| 2026-03-25 | 21.76x |
| 2026-03-24 | 21.64x |
| 2026-03-23 | 21.84x |
| 2026-03-20 | 20.84x |
| 2026-03-19 | 21.24x |
| 2026-03-18 | 20.74x |
| 2026-03-17 | 21.22x |
| 2026-03-16 | 20.35x |
| 2026-03-13 | 19.67x |
| 2026-03-12 | 20.02x |
| 2026-03-11 | 21.05x |
| 2026-03-10 | 20.35x |
| 2026-03-09 | 21.08x |
| 2026-03-06 | 20.95x |
| 2026-03-05 | 21.16x |
| 2026-03-04 | 22.01x |
| 2026-03-03 | 22.07x |
| 2026-03-02 | 22.91x |
| 2026-02-27 | 23.05x |
| 2026-02-26 | 23.98x |
| 2026-02-25 | 23.82x |
| 2026-02-24 | 23.48x |
| 2026-02-23 | 22.90x |
| 2026-02-20 | 24.09x |
| 2026-02-19 | 24.01x |
| 2026-02-18 | 24.20x |
| 2026-02-17 | 23.71x |
| 2026-02-13 | 23.65x |
| 2026-02-12 | 23.25x |
| 2026-02-11 | 25.10x |
| 2026-02-10 | 24.94x |
| 2026-02-09 | 24.43x |
| 2026-02-06 | 23.76x |
| 2026-02-05 | 22.14x |
| 2026-02-04 | 20.20x |
| 2026-02-03 | 19.62x |
| 2026-02-02 | 20.51x |
| 2026-01-30 | 20.43x |
| 2026-01-29 | 20.58x |
| 2026-01-28 | 20.69x |
| 2026-01-27 | 20.98x |
| 2026-01-26 | 21.06x |
| 2026-01-23 | 21.21x |
| 2026-01-22 | 21.23x |
| 2026-01-21 | 21.37x |
| 2026-01-20 | 20.77x |
| 2026-01-16 | 21.58x |
| 2026-01-15 | 21.58x |
| 2026-01-14 | 21.27x |
| 2026-01-13 | 21.40x |
| 2026-01-12 | 21.65x |
| 2026-01-09 | 21.76x |
| 2026-01-08 | 21.46x |
| 2026-01-07 | 20.95x |
| 2026-01-06 | 21.06x |
| 2026-01-05 | 20.04x |
| 2026-01-02 | 19.48x |
| 2025-12-31 | 19.50x |
| 2025-12-30 | 19.77x |
| 2025-12-29 | 19.73x |
| 2025-12-26 | 19.80x |
| 2025-12-24 | 19.73x |
| 2025-12-23 | 19.58x |
| 2025-12-22 | 19.93x |
| 2025-12-19 | 19.71x |
| 2025-12-18 | 20.22x |
| 2025-12-17 | 20.10x |
| 2025-12-16 | 20.41x |
| 2025-12-15 | 20.39x |
| 2025-12-12 | 20.76x |
| 2025-12-11 | 20.55x |
| 2025-12-10 | 20.64x |
| 2025-12-09 | 19.89x |
| 2025-12-08 | 19.71x |
| 2025-12-05 | 19.64x |
| 2025-12-04 | 19.59x |
| 2025-12-03 | 19.35x |
| 2025-12-02 | 18.79x |
| 2025-12-01 | 18.22x |
| 2025-11-28 | 18.29x |
| 2025-11-26 | 18.29x |
| 2025-11-25 | 18.33x |
| 2025-11-24 | 17.81x |
| 2025-11-21 | 17.66x |
| 2025-11-20 | 16.34x |
| 2025-11-19 | 16.46x |
| 2025-11-18 | 16.27x |
| 2025-11-17 | 16.31x |
| 2025-11-14 | 16.92x |
| 2025-11-13 | 17.23x |
| 2025-11-12 | 17.54x |
| 2025-11-11 | 17.92x |
| 2025-11-10 | 17.07x |
| 2025-11-07 | 16.61x |
| 2025-11-06 | 16.46x |
| 2025-11-05 | 16.94x |
| 2025-11-04 | 15.10x |
| 2025-11-03 | 15.45x |
| 2025-10-31 | 15.37x |
| 2025-10-30 | 15.44x |
| 2025-10-29 | 14.65x |
| 2025-10-28 | 14.80x |
| 2025-10-27 | 15.10x |
| 2025-10-24 | 15.05x |
| 2025-10-23 | 15.14x |
| 2025-10-22 | 15.09x |
| 2025-10-21 | 15.17x |
| 2025-10-20 | 15.01x |
| 2025-10-17 | 14.47x |
| 2025-10-16 | 14.40x |
| 2025-10-15 | 14.23x |
| 2025-10-14 | 14.39x |
| 2025-10-13 | 14.36x |
| 2025-10-10 | 13.91x |
| 2025-10-09 | 14.64x |
| 2025-10-08 | 14.79x |
| 2025-10-07 | 14.47x |
| 2025-10-06 | 14.60x |
| 2025-10-03 | 14.68x |
| 2025-10-02 | 14.26x |
| 2025-10-01 | 14.12x |
| 2025-09-30 | 13.84x |
| 2025-09-29 | 13.98x |
| 2025-09-26 | 13.96x |
| 2025-09-25 | 13.80x |
| 2025-09-24 | 14.20x |
| 2025-09-23 | 14.30x |
| 2025-09-22 | 14.56x |
| 2025-09-19 | 14.59x |
| 2025-09-18 | 14.73x |
| 2025-09-17 | 14.35x |
| 2025-09-16 | 14.64x |
| 2025-09-15 | 14.55x |
| 2025-09-12 | 14.61x |
| 2025-09-11 | 15.13x |
| 2025-09-10 | 14.77x |
| 2025-09-09 | 15.13x |
| 2025-09-08 | 15.25x |
| 2025-09-05 | 15.52x |
| 2025-09-04 | 14.99x |
| 2025-09-03 | 14.70x |
| 2025-09-02 | 15.28x |
| 2025-08-29 | 15.86x |
| 2025-08-28 | 15.76x |
| 2025-08-27 | 15.87x |
| 2025-08-26 | 15.84x |
| 2025-08-25 | 16.23x |
| 2025-08-22 | 16.78x |
| 2025-08-21 | 15.71x |
| 2025-08-20 | 16.06x |
| 2025-08-19 | 16.08x |
| 2025-08-18 | 16.22x |
| 2025-08-15 | 15.92x |
| 2025-08-14 | 15.97x |
| 2025-08-13 | 16.32x |
| 2025-08-12 | 15.69x |
| 2025-08-11 | 15.00x |
| 2025-08-08 | 15.61x |
| 2025-08-07 | 15.48x |
| 2025-08-06 | 15.25x |
| 2025-08-05 | 16.29x |
| 2025-08-04 | 16.06x |
| 2025-08-01 | 15.90x |
| 2025-07-31 | 14.96x |
| 2025-07-30 | 24.34x |
| 2025-07-29 | 24.63x |
| 2025-07-28 | 24.80x |
| 2025-07-25 | 24.59x |
| 2025-07-24 | 24.17x |
| 2025-07-23 | 24.41x |
| 2025-07-22 | 23.15x |
| 2025-07-21 | 22.51x |
| 2025-07-18 | 22.73x |
| 2025-07-17 | 22.92x |
| 2025-07-16 | 22.67x |
| 2025-07-15 | 22.99x |
| 2025-07-14 | 23.81x |
| 2025-07-11 | 24.18x |
| 2025-07-10 | 24.46x |
| 2025-07-09 | 23.95x |
| 2025-07-08 | 23.32x |
| 2025-07-07 | 23.12x |
| 2025-07-03 | 23.49x |
| 2025-07-02 | 23.51x |
| 2025-07-01 | 23.17x |
| 2025-06-30 | 22.55x |
| 2025-06-27 | 22.45x |
| 2025-06-26 | 22.35x |
| 2025-06-25 | 22.28x |
| 2025-06-24 | 22.20x |
| 2025-06-23 | 21.81x |
| 2025-06-20 | 21.60x |
| 2025-06-18 | 21.38x |
| 2025-06-17 | 20.77x |
| 2025-06-16 | 21.69x |
| 2025-06-13 | 21.11x |
| 2025-06-12 | 21.59x |
| 2025-06-11 | 22.07x |
| 2025-06-10 | 22.39x |
| 2025-06-09 | 21.49x |
| 2025-06-06 | 21.45x |
| 2025-06-05 | 21.41x |
| 2025-06-04 | 21.37x |
| 2025-06-03 | 21.27x |
| 2025-06-02 | 21.19x |
| 2025-05-30 | 21.49x |
Showing the most recent 260 of 4,566 data points. The chart above shows the full history.
Related Metrics
About Align Technology, Inc.
Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Joseph Hogan